Simon Allen - 07 Feb 2022 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Executive Officer
Signature
/s/ James R. Merchant, as Attorney-in-Fact
Issuer symbol
ANEB
Transactions as of
07 Feb 2022
Net transactions value
$0
Form type
4
Filing time
07 Feb 2022, 15:07:20 UTC
Previous filing
07 Feb 2022
Next filing
03 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Option to purchase Common Stock Award $0 +625,000 $0.000000 625,000 07 Feb 2022 Common Stock 625,000 $6.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Allen received a stock option to purchase 625,000 shares of the Issuer's common stock pursuant to the Issuer's 2020 Stock Incentive Plan, which will vest in equal quarterly installments commencing on April 1, 2022 through January 1, 2026.